S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field

Targeted Talks

Player FM - Internet Radio Done Right

اضافه شده در three سال پیش

محتوای ارائه شده توسط Targeted Talks. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Targeted Talks یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

All About Change

1
Professional football player Jonathan Jones: Mentorship and Making an Impact in Your Community 22:49

13 روز پیش22:49

پخش در آینده

لیست ها

پسندیدن

دوست داشته شد

22:49

Jonathan Jones is an NFL cornerback for the Washington Commanders who rose from the undrafted ranks to become two-time Super Bowl champion with the New England Patriots, a businessman, philanthropist, and licensed pilot. In 2019, Jonathan founded the Jonathan Jones Next Step Foundation in 2019, a platform dedicated to empowering youth through education, professional development, and mentorship. The foundation works to alleviate food insecurity, promote women in stem and sports, and to promote professional development in the communities where he lives. Jay and Jonathan talk about investing in the communities they live in, acknowledging the people who helped you become the person you are, and paying that same investment forward to the next generation. Episode Chapters 0:00 intro 1:24 Building local connections 4:25 Jonathan’s mentors and mentees 10:54 Jonathan’s pride in his mentees’ successes 13:04 how Jonathan chooses his causes 14:08 Jonathan’s support for girls and young women 17:19: Jonathan’s passion for flying 19:40 The Next Step Foundation 20:29 Goodbye For video episodes, watch on www.youtube.com/@therudermanfamilyfoundation Stay in touch: X: @JayRuderman | @RudermanFdn LinkedIn: Jay Ruderman | Ruderman Family Foundation Instagram: All About Change Podcast | Ruderman Family Foundation To learn more about the podcast, visit https://allaboutchangepodcast.com/ Looking for more insights into the world of activism? Be sure to check out Jay’s brand new book, Find Your Fight , in which Jay teaches the next generation of activists and advocates how to step up and bring about lasting change. You can find Find Your Fight wherever you buy your books, and you can learn more about it at www.jayruderman.com .…

۲ سال پیش 11:50

MP3•خانه قسمت

In our first episode of Emerging Experts, Aakash Desai, MD, MPH, discusses his journey through the oncology field by reminiscing on the encouraging guidance of his mentors, personal research goals, and his experiences thus far as an oncologist.

71 قسمت

#Science #Fitness #Targeted Talks

S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field

Targeted Talks

published ۲ سال پیش

اشتراک گذاری

MP3•خانه قسمت

71 قسمت

#Science #Fitness #Targeted Talks

همه قسمت ها

1
S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning 36:35

11 روز پیش36:35

36:35

In this episode of Emerging Experts, Xiaojie Zhang, MD, a hematology/oncology fellow, and Akshat Singhal, PhD, a postdoctoral scholar, both at UC San Diego, shed light on innovative research leveraging deep learning to predict how patients with ER-positive/HER2-negative (ER+/HER2-) breast cancer will respond to palbociclib (Ibrance), a common first-line treatment for this patient population. Their work, fueled by the desire to improve precision oncology, demonstrates the significant potential of artificial intelligence (AI) in guiding cancer care.…

1
S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall 14:48

۶ weeks پیش14:48

14:48

In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.…

1
S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain 27:50

۸ weeks پیش27:50

27:50

David A. Russler-Germain, MD, PhD, physician-scientist at Washington University School of Medicine and Siteman Cancer Center, discusses his path in oncology and the many advancements shaping lymphoma treatment today.

1
S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia 8:13

11 weeks پیش8:13

8:13

In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan for the treatment of patients with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have received prior systemic therapy.

1
S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment 35:13

14 weeks پیش35:13

35:13

In this episode of Targeted Talks, Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses the exciting advancements of artificial intelligence in 2024, specifically focusing on its transformative impact on early cancer detection.

1
S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research 16:28

23 weeks پیش16:28

16:28

In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the transformative impact of artificial intelligence in oncology.

1
S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander 27:56

25 weeks پیش27:56

27:56

In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.…

1
S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology 16:20

27 weeks پیش16:20

16:20

Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing research.

1
S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer 13:41

30 weeks پیش13:41

13:41

In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the phase 3 EMERALD trial.…

1
S5 Ep16: Foran Goes Beyond the Basics of BPDCN 22:32

32 weeks پیش22:32

22:32

In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm.

1
S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates 30:43

34 weeks پیش30:43

30:43

In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.…

1
S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel 16:05

36 weeks پیش16:05

16:05

In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.

1
S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US 19:23

38 weeks پیش19:23

19:23

In this episode of Emerging Experts, Yu Fujiwara, shares his journey from Japan to the United States and his path to becoming a specialist in hematology and oncology.

1
S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role 18:04

41 weeks پیش18:04

18:04

In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.

1
S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine 23:58

43 weeks پیش23:58

23:58

Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.

1
S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM 20:11

45 weeks پیش20:11

20:11

In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.

1
S5 Ep9: Unlocking the Potential of Technology in Community Oncology 25:49

49 weeks پیش25:49

25:49

In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world of technology in the community oncology setting.

1
S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology 14:20

51 weeks پیش14:20

14:20

In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.

1
S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches 26:53

1 year پیش26:53

26:53

In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women’s oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing is changing the field.…

1
S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding 19:05

1 year پیش19:05

19:05

In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.

1
S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC 22:32

1 year پیش22:32

22:32

In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20 insertion mutation-positive non-small cell lung cancer.

1
S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC 19:03

1 year پیش19:03

19:03

In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy.

1
S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing 22:04

1 year پیش22:04

22:04

In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.

1
S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC 20:06

1 year پیش20:06

20:06

In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.

1
S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer 23:52

1 year پیش23:52

23:52

In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina Health, delves into the critical topic of prostate cancer screening, particularly for men within a community setting, and discusses some of the recent advancements in the prostate cancer space.…

1
S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care 15:49

1 year پیش15:49

15:49

In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.…

1
S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities 15:57

1 year پیش15:57

15:57

In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to discuss his interest and research in immunotherapy toxicities.

1
S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC 9:24

1 year پیش9:24

9:24

In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.

1
S4 Ep17: Bridging Science and Compassion in Cancer Care 20:24

1 year پیش20:24

20:24

In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego (UCSD) Medical Center, UCSD Health, to discuss insights into her passion for oncology and some of the experiences that have helped to shape her career.…

1
S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer 25:35

۲ years پیش25:35

25:35

In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.

به بیش از 500 موضوع گوش کنید

مشابه Targeted Talks

پادکست هایی که ارزش شنیدن دارند

Targeted Talks « » S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field

S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field

پادکست هایی که ارزش شنیدن دارند

به Player FM خوش آمدید!

مشابه Targeted Talks

راهنمای مرجع سریع

Targeted Talks « »
S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field